Renovaro Biosciences Inc. (NASDAQ: RENB)
$1.41
+0.0100 ( +0.71% ) 143.7K
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Market Data
Open
$1.41
Previous close
$1.40
Volume
143.7K
Market cap
$218.58M
Day range
$1.39 - $1.45
52 week range
$0.66 - $5.25
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jul 15, 2024 |
| 4 | Insider transactions | 1 | Jul 08, 2024 |
| 4 | Insider transactions | 1 | Jul 03, 2024 |
| 4 | Insider transactions | 1 | Jul 03, 2024 |
| 8-k | 8K-related | 13 | Jul 03, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |